Xiang Qian XQ Lin
About
Xiang Qian XQ Lin is from Singapore, Singapore. XiangQian is currently Founder at Carcell Biopharma, located in Shanghai, Shanghai, China. XiangQian also works as Founding Investor at Nuevocor, a job XiangQian has held since Jun 2021. Another title XiangQian currently holds is Chairman and CEO at Esco.
Xiang Qian XQ Lin's email is available on Finalscout.com free of charge. This database has a wealth of information on over half a billion business professionals and two hundred million companies.
Xiang Qian XQ Lin's current jobs
Global CGT platform
AAV 2.0 focused on rare cardiac indications
Esco 3.0 — with a refreshed corporate leadership team, driving R&D, M&A, expedited expansion in China and the US, Esco Business System (EBS) to improve operating efficiency.
Gene therapy 3.0. An EVX (and 2020 Fierce 15) company co-founded with Harvey Lodish, Minh Le and Jiahai Shi. Developing non-viral gene therapies based on red blood cell extracellular vesicles — highly scalable, re-dosable, unique tissue tropism (also targetable) and large transgene capacity. Technology published in Nature Communications.
One of the pioneering biotech company builders from Singapore, EVX Ventures builds, incubates, and invests in biotech companies, originating from innovative technologies sourced globally. With a focus on disruptive therapeutics platform technologies and novel therapeutic modalities, we nurture promising early-stage life science startups to make a lasting and meaningful impact for patients.